Global Psychiatric Medications Market is expected to grow at a CAGR of 2.7% from 2020 to 2027
Rigorous scientific research has led to substantial evidence of the involvement of 2 neurotransmitters to be linked with the pathophysiology of psychosis which is glutamate and dopamine. Researchers are of the opinion that if the abnormality in the glutamate and dopamine interaction is resolved in the early stages of the mental illness it can save a patient from entering into psychosis. Promising product pipeline will fortify the psychiatric market growth during the forecast period. The treatment regimen for psychiatric disorders has undergone tremendous research and development over the last 5…
Read More